SPEED DUO FELVFIV

Informazioni principali

  • Nome commerciale:
  • SPEED DUO FELV/FIV
  • Confezione:
  • Scatola da 20 test
  • Tipo di ricetta:
  • Libera vendita
  • Utilizzare per:
  • Animali
  • Tipo di medicina:
  • Dispositivo medico

Documenti

  • per i professionisti:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per i professionisti.

Localizzazione

  • Disponibile in:
  • SPEED DUO FELV/FIV
    Italia
  • Lingua:
  • italiano

Informazioni terapeutiche

  • Gruppo terapeutico:
  • Gatti
  • Area terapeutica:
  • Tutti gli altri prodotti non terapeutici
  • Indicazioni terapeutiche:
  • Diagnosi rapida FeLV/FIV su plasma, siero o sangue intero (con anticoagulante).
  • Dettagli prodotto:
  • Posologia: Con una pipetta mantenuta in posizione verticale, deporre una goccia del campione in ogni pozzetto. Deporre 5 gocce di REAGENTE in ogni pozzetto. Tempo di lettura: da 10 a 15 minuti di migrazione.

Altre informazioni

Status

  • Fonte:
  • Ministero della Salute - Italia
  • Numero dell'autorizzazione:
  • 920339090
  • Ultimo aggiornamento:
  • 14-08-2017

Foglio illustrativo: composizione, posologia, indicazioni, interazioni, gravidanza, allattamento, effetti indesiderati, controindicazioni

Speed Duo FeLV/FIV

Q INTERESSE CLINICO

0S]PY\ZKLSSHSL\JLTPHMLSPUH-L3=LPS]PY\ZKLSS»PTT\UVKLÄJPLUaH

felina (FIV) sono due retrovirus diffusi in tutto il mondo. Essi

]LUNVUV[YHZTLZZPWYPUJPWHSTLU[LH[[YH]LYZVJVU[H[[PYH]]PJPUH[P[YH

NH[[PZHSP]HZLJYLaPVUPUHZHSPMLJP

PUMLaPVUP

KV]\[L

]PY\Z

-L3=

-0=

WYLZLU[HUV

MVY[P

ZVTPNSPHUaLJSPUPJOLPSJOLYLUKLTVS[VKPMÄJPSL\UHSVYVKPHNUVZP

KPMMLYLUaPHSL!

PZPU[VTPZVUVTVS[V]HYPHIPSPLZWLZZVWVJVL]PKLU[P

ZVUV MYLX\LU[P MHZP HZPU[VTH[PJOL KP ]HYPH K\YH[H LZPZ[LUaH KP

portatori sani)

SLK\LTHSH[[PLZVUVHJJVT\UH[LKHZ]HYPH[PZPU[VTP!HIIH[[PTLU[V

HUVYLZZPHPWLY[LYTPHZPUKYVTLKHPTT\UVKLÄJPLUaHHULTPH

*VUZPNSPHIPSL LMML[[\HYL \U TVUP[VYNNPV YLNVSHYL KLSSH JVUKPaPVUL

PUML[[P]H KLSS»HUPTHSL PU THUPLYH [HSL KH WV[LY PU[LY]LUPYL JVU

[YH[[HTLU[P

HKLN\H[P

ZVY]LNSPHUaH

HUPTHSP

PUML[[P

L]LU[\HSL

ZLWHYHaPVUL KHP ZVNNL[[P ZHUP ZLYPSPaaHaVUL [LYHWPL KP Z\WWVY[V

L[J

Q PRINCIPIO

:WLLK+\V-L3=-0=u\U[LZ[X\HSP[H[P]VYHWPKVIHZH[VZ\SWYPUJPWPV

KLSS»PTT\UVJYVTH[VNYHÄHZ\TLTIYHUHJOLWLYTL[[LKPTL[[LYL

PUL]PKLUaHSHWYLZLUaHKPHU[PNLUPKLS-L3=LKPHU[PJVYWPHU[P-0=

ULSNH[[V

7LYVNUP[LZ[uZ\MÄJPLU[LKLWVYYL\UHNVJJPHKLSJHTWPVULZPLYV

IT-1

Speed Duo FeLV/FIV

Kit di diagnosi veterinaria

Solo per uso in vitro

WSHZTH V ZHUN\L PU[LYV JVU HU[PJVHN\SHU[L ULS WVaaL[[V KLP

JHTWPVUP <UH ]VS[H KLWVZ[V PS JHTWPVUL SL WHY[PJLSSL JVSVYH[L

KLS JVUP\NH[V ZP SLNHUV HNSP HU[PNLUP 7 KLS -L3= WHY[L -L3= L

HNSPHU[PJVYWPHU[P-0=KLSNH[[VWHY[L-0=0JVTWSLZZPJVUP\NH[V

HU[PNLUP

KLS

-L3=

JVUP\NH[VHU[PJVYWP

HU[P-0=

JVZy

MVYTH[P

TPNYHUVWLYJHWPSSHYP[nZ\SSHTLTIYHUH=LUNVUVX\PUKPJH[[\YH[PKH

HU[PJVYWPZWLJPÄJPHU[P-L3=LKHHU[PNLUPZWLJPÄJPWLYPS-0=ÄZZH[P

Z\SSH TLTIYHUH L MVYTHUV WLY HJJ\T\SV KP WHY[PJLSSL JVSVYH[L

\UHIHUKH[LZ[KPJVSVYLYVZH3»PUZPLTLTPNYHZ\SZ\WWVY[VÄUVH

YHNNP\UNLYLS»LZ[YLTP[nKLSSHTLTIYHUHKV]LSLWHY[PJLSSLJVSVYH[L

YPTHULU[P MVYTHUV \UH IHUKH KP JVU[YVSSV YVZH JOL JVUMLYTH SH

JVYYL[[HLZLJ\aPVULKLS[LZ[

Q PROTOCOLLO OPERATIVO

PER OGNI TEST PREVEDERE:

JLSSH[LZ[WPWL[[HTVUV\ZVPSÅHJVULKPYLHNLU[L

<[PSPaaHYLPYLHNLU[PH[LTWLYH[\YHHTIPLU[L

Non mescolare mai reagenti di lotti diversi.

1/ DEPOSITO DEL CAMPIONE:

:PLYVWSHZTHZHUN\LPU[LYVJVUHU[PJVHN\SHU[L,+;(VLWHYPUH!

JVU\UHWPWL[[HTVUV\ZVTHU[LU\[HPUWVZPaPVUL]LY[PJHSLdeporre

1 gocciaKPJHTWPVULULSWVaaL[[VKLPJHTWPVUP

2/ DEPOSITO DEL REAGENTE:

 (NNP\UNLYL PS YLHNLU[L Z\IP[V KVWV H]LY KLWVZ[V PS JHTWPVUL

4HU[LULYLPSÅHJVULKPYLHNLU[LPUWVZPaPVUL]LY[PJHSLLaggiungerne

5 goccePUVNUPWVaaL[[VKLSJHTWPVUL

:L SL TPNYHaPVUL UVU PUPaPH LU[YV  TPU\[P aggiungere altre

2 gocceKPYLHNLU[LULSWVaaL[[VKLSJHTWPVUL

IT-2

3/ LETTURA E INTERPRETAZIONE DEI RISULTATI :

3LNNLYLPSYPZ\S[H[VKVWV15 minuti di migrazione:

-Se il TEST È NEGATIVOJVTWHYL1 banda rosa nella

ÄULZ[YHKPSL[[\YHIHUKHKPJVU[YVSSV

-Se il TEST È POSITIVOJVTWHPVUV2 bande rosaILU

KPZ[PU[L ULSSH ÄULZ[YH KP SL[[\YH IHUKH [LZ[  IHUKH KP

JVU[YVSSV

3HJVTWHYZHKP\UHIHUKH[LZ[KVWVZVSVTPU\[PKP

TPNYHaPVULWLYTL[[LKPJVUJS\KLYLJOLPS[LZ[uWVZP[P]V

<UH JVSVYHaPVUL HUJOL TVS[V SPL]L KLSSH Z[YPZJPH [LZ[

KL]LLZZLYLJVUZPKLYH[HJVTL\UYPZ\S[H[VWVZP[P]V

-3»HZZLUaHKLSSHIHUKHKPJVU[YVSSVZPNUPÄJHJOLPS[LZ[

non è valido.

Q RACCOMANDAZIONI

‹:;()030;±*65:,9=(A065,!

TLZP

[LTWLYH[\YH

HTIPLU[L

WHY[PYL

KHSSH

KH[H

MHIIYPJHaPVUL3HKH[HKPZJHKLUaHuYPWVY[H[HZ\SRP[LZ\VNUPI\Z[H

JVU[LULU[LP[LZ[

 *VUZLY]HYL H [LTWLYH[\YH HTIPLU[L [YH   ‡* L  ‡* 5VU

LZWVYYLPS[LZ[H[LTWLYH[\YL[YVWWVLSL]H[LVPUMLYPVYPH‡*

‹ CAMPIONI :

 0 JHTWPVUP KP ZPLYV WSHZTH V ZHUN\L PU[LYV JVU HU[PJVHN\SHU[L

KL]VUVLZZLYLH[LTWLYH[\YHHTIPLU[LHSTVTLU[VKLSS»\[PSPaaV

*VUZLY]HaPVULKLPJHTWPVUPÄUVHVYL!JVUZLY]HYLZPLYVWSHZTH

VZHUN\LPU[LYVJVUHU[PJVHN\SHU[LH[LTWLYH[\YHHTIPLU[L

 *VUZLY]HaPVUL KLP JHTWPVUP ÄUV H  VYL! JVUZLY]HYL ZPLYV

V WSHZTH [YH  ‡* L  ‡* PU MYPNVYPMLYV 3H JVUZLY]HaPVUL KLS

ZHUN\L PU[LYV WLY KP]LYZL VYL [YH  ‡* L  ‡* W\~ WYV]VJHYL

\U»LTVSPZP WHYaPHSL UVU ]PZPIPSL H VJJOPV U\KV JOL W\~ YLUKLYL

IT-3

WPƒKPMÄJPSLS»PU[LYWYL[HaPVULKLS[LZ[

6S[YLSLVYLJVUZLY]HYLZPLYVLWSHZTHH‡*5VUJVUNLSHYL

THP\UJHTWPVULKPZHUN\LPU[LYV

‹ PRECAUZIONI PER LA MANIPOLAZIONE :

 7LY V[[LULYL \UH TPNYHaPVUL JVYYL[[H KLS JHTWPVUL TL[[LYL SH

JLSSH[LZ[Z\\UHZ\WLYÄJPLWPHUHLVYPaaVU[HSL

7LYZ[HUKHYKPaaHYLSHX\HU[P[nKPJHTWPVULULJLZZHYPHWLYJPHZJ\U

[LZ[\[PSPaaHYLLZJS\ZP]HTLU[LSLWPWL[[LWYLZLU[PULSSHJVUMLaPVUL

7LYKLWVYYLJVYYL[[HTLU[LPSJHTWPVULLPSYLHNLU[LTHU[LULYLPS

ÅHJVULJVU[HNVJJLKLSYLHNLU[LLSHWPWL[[HPUWVZPaPVUL]LY[PJHSL

‹ ALTRE RACCOMANDAZIONI :

 +\YHU[L S»LZLJ\aPVUL KLS [LZ[ SH ÄULZ[YH KP SL[[\YH W\~ TVZ[YHYL

\UHSPL]LJVSVYHaPVULYVZHJOLUVUOHHSJ\UHJVUZLN\LUaHZ\SSH

X\HSP[nKLSYPZ\S[H[V

- Non mescolare reagenti di lotti diversi.

 3HZJPHYL JOL P YLHNLU[P YHNNP\UNHUV SH [LTWLYH[\YH HTIPLU[L

WYPTHKLSS»\ZV

<[PSPaaHYL\UHU\V]HWPWL[[HTVUV\ZVWLYVNUP[LZ[

8\LZ[L YHJJVTHUKHaPVUP JVZ[P[\PZJVUV ZVSV \UH N\PKH PU X\HU[V

UVUZPW\~WYL[LUKLYLJOLHSJ\UTL[VKVKPHNUVZ[PJVZPHWYLJPZVHS

 3VZJVWVKPX\LZ[V[LZ[uHP\[HYLPS]L[LYPUHYPVHKPHNUVZ[PJHYL

PS-L3=LPS-0=YPZWL[[P]HTLU[LTLKPHU[LYPSL]HTLU[VKLNSPHU[PNLUP

KLS -L3= L KLNSP HU[PJVYWP HU[P-0= 3»PU[LYWYL[HaPVUL KLS [LZ[ KH

WHY[L KLS ]L[LYPUHYPV KV]Yn ZLTWYL [LULYL JVU[V KLSS»HUHTULZP

KLSS»LZHTL JSPUPJV KLSS»HUPTHSL L KLS YPZ\S[H[V KP L]LU[\HSP HS[YP

LZHTPJVTWSLTLU[HYP3HKPHNUVZPÄUHSLYLZ[H\UHWYLYVNH[P]HKLS

]L[LYPUHYPVJ\YHU[LLKuZV[[VSHZ\HYLZWVUZHIPSP[n

)PV =L[V ;LZ[

Z\VP

KPZ[YPI\[VYP

UVU

WVZZVUV

LZZLYL

YP[LU\[P

YLZWVUZHIPSP KLSSL JVUZLN\LUaL SLNH[L H \U \[PSPaaV ZJVYYL[[V V H

\U»PU[LYWYL[HaPVULZJVYYL[[HKLPYPZ\S[H[PMVYUP[PKHX\LZ[V[LZ[

IT-4

9LM!XPROTODFF-V V1

4HU\MHJ[\YLKI`-HIYPX\tWHY-HIYPJHKVWVY4HU\MHJ[\YHKV

por / Prodotto da / —¾Ñ¾ÐÈÂ֝×ÂѾ ¾Í»ÑÅË /LYNLZ[LSS[]VU

=LY]HHYKPNKKVVY!

BIO VETO TEST

(=,5<,+,964,

3(:,@5,:<94,9-9(5*,

17-1-2019

SRAM recalls three-speed internal gear hub with coaster brake

SRAM recalls three-speed internal gear hub with coaster brake

The brake can fail, posing a crash or fall hazard to the rider.

Health Canada

12-1-2019

Scientific Opinion on Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3): consideration of genotoxicity data on alicyclic aldehydes with α,β‐unsaturation in ring/side‐chain and precursors from chemical subgroup 2.2 of FGE.19

Scientific Opinion on Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3): consideration of genotoxicity data on alicyclic aldehydes with α,β‐unsaturation in ring/side‐chain and precursors from chemical subgroup 2.2 of FGE.19

Published on: Fri, 11 Jan 2019 The EFSA Panel on Food Additives and Flavourings was requested to evaluate the genotoxic potential of flavouring substances from subgroup 2.2 of FGE.19 in the Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3). In FGE.208Rev1, the Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) evaluated genotoxicity studies on the representative substance p‐mentha‐1,8‐dien‐7‐al [FL‐no: 05.117], which was found to be genotoxic in vivo. The Panel conclu...

Europe - EFSA - European Food Safety Authority EFSA Journal

12-1-2019

Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from Bacillus subtilis (strain XAS)

Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from Bacillus subtilis (strain XAS)

Published on: Fri, 11 Jan 2019 The EFSA Panel on Food Additives and Flavourings was requested to evaluate the genotoxic potential of flavouring substances from subgroup 2.2 of FGE.19 in the Flavouring Group Evaluation 208 Revision 3 (FGE.208Rev3). In FGE.208Rev1, the Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) evaluated genotoxicity studies on the representative substance p‐mentha‐1,8‐dien‐7‐al [FL‐no: 05.117], which was found to be genotoxic in vivo. The Panel conclu...

Europe - EFSA - European Food Safety Authority EFSA Journal

10-1-2019

Stanley Black & Decker Canada Corp. recalls DEWALT DWD110 and DWD112 variable speed reversing drills

Stanley Black & Decker Canada Corp. recalls DEWALT DWD110 and DWD112 variable speed reversing drills

The internal wiring of the DEWALT 3/8-inch variable speed reversing drills can come into contact with internal parts, posing a risk of electrical shock.

Health Canada

17-12-2018

Duodenoscope reprocessing

Duodenoscope reprocessing

Update - interim results from FDA surveillance studies

Therapeutic Goods Administration - Australia

10-12-2018

Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data

Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data

FDA provides updates to postmarketing studies that agency ordered three manufacturers of duodenoscopes to conduct to assess bacterial contamination of devices.

FDA - U.S. Food and Drug Administration

20-10-2018

Scientific Opinion on Flavouring Group Evaluation 200, Revision 1 (FGE.200 Rev.1): 74 α,β‐unsaturated aliphatic aldehydes and precursors from chemical subgroup 1.1.1 of FGE.19

Scientific Opinion on Flavouring Group Evaluation 200, Revision 1 (FGE.200 Rev.1): 74 α,β‐unsaturated aliphatic aldehydes and precursors from chemical subgroup 1.1.1 of FGE.19

Published on: Fri, 19 Oct 2018 00:00:00 +0200 The Panel on Food Additives and Flavourings of the European Food Safety Authority was requested to evaluate the genotoxic potential of 74 flavouring substances from subgroup 1.1.1 of FGE.19 in the Flavouring Group Evaluation 200 Revision 1 (FGE.200 Rev1). In FGE.200, genotoxicity studies were provided for one representative substance, namely hex‐2(trans)‐enal [FL‐no: 05.073], and for other two substances in the same subgroup, namely 2‐dodecenal [FL‐no: 05.03...

Europe - EFSA - European Food Safety Authority Publications

18-10-2018

Scientific Opinion on Flavouring Group Evaluation 201 Revision 2 (FGE.201Rev2): 2‐alkylated, aliphatic, acyclic alpha,beta‐unsaturated aldehydes and precursors, with or without additional double‐bonds, from chemical subgroup 1.1.2 of FGE.19

Scientific Opinion on Flavouring Group Evaluation 201 Revision 2 (FGE.201Rev2): 2‐alkylated, aliphatic, acyclic alpha,beta‐unsaturated aldehydes and precursors, with or without additional double‐bonds, from chemical subgroup 1.1.2 of FGE.19

Published on: Wed, 17 Oct 2018 00:00:00 +0200 The Panel on Food Additives and Flavourings of the European Food Safety Authority was requested to consider in this revision 2 of Flavouring Group Evaluation 201, the additional data on genotoxicity submitted by the Industry on two substances, 2‐methylpent‐2‐enal [FL‐no: 05.090] and 2 methylcrotonaldehyde [FL‐no: 05.095], from subgroup 1.1.2 of FGE.19. In FGE.201Rev1, the Panel concluded that further data were required in order to clarify the genotoxic poten...

Europe - EFSA - European Food Safety Authority Publications

23-8-2018

The Manhattan Toy Company recalls Pull-Back Speedy Jets

The Manhattan Toy Company recalls Pull-Back Speedy Jets

The rubber tires can separate from the wheels posing a small parts choking hazard for small children.

Health Canada

20-6-2018

Bumbleride Inc recalls Bumbleride Speed 3-wheel jogging stroller

Bumbleride Inc recalls Bumbleride Speed 3-wheel jogging stroller

Health Canada's sampling and evaluation program has determined that this jogging stroller does not meet the sharp edge requirements of the Carriages and Strollers Regulations in Canada. The metal edge of the back hinge located on the right side of the jogging stroller can be sharp, posing a potential risk of cut or laceration.

Health Canada

14-12-2018

#ICYMI: Jeff Shuren, Director of the Center for Devices & Radiological  Health, released a statement on updated safety  communication about  rates of duodenoscope contamination from  preliminary postmarket data.  Read the statement here:  https://go.usa.g

#ICYMI: Jeff Shuren, Director of the Center for Devices & Radiological Health, released a statement on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data. Read the statement here: https://go.usa.g

#ICYMI: Jeff Shuren, Director of the Center for Devices & Radiological Health, released a statement on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data. Read the statement here: https://go.usa.gov/xE3kf  #MedicalDevice

FDA - U.S. Food and Drug Administration

10-12-2018

.@US_FDA is emphasizing the importance of manual cleaning prior to disinfection or sterilization and proper servicing of duodenoscopes. Read more:  https://go.usa.gov/xPShF  #MedicalDevice #FDApic.twitter.com/HiJbgPnsPt

.@US_FDA is emphasizing the importance of manual cleaning prior to disinfection or sterilization and proper servicing of duodenoscopes. Read more: https://go.usa.gov/xPShF  #MedicalDevice #FDApic.twitter.com/HiJbgPnsPt

. @US_FDA is emphasizing the importance of manual cleaning prior to disinfection or sterilization and proper servicing of duodenoscopes. Read more: https://go.usa.gov/xPShF  #MedicalDevice #FDA pic.twitter.com/HiJbgPnsPt

FDA - U.S. Food and Drug Administration

29-10-2018

DuoPlavin (Sanofi Clir SNC)

DuoPlavin (Sanofi Clir SNC)

DuoPlavin (Active substance: clopidogrel / acetylsalicylic acid) - Centralised - 2-Monthly update - Commission Decision (2018)7255 of Mon, 29 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1143/WS/1433/0050

Europe -DG Health and Food Safety

2-10-2018

Xigduo (AstraZeneca AB)

Xigduo (AstraZeneca AB)

Xigduo (Active substance: dapagliflozin/metformin) - Centralised - Renewal - Commission Decision (2018)6462 of Tue, 02 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2672/R/44

Europe -DG Health and Food Safety

22-7-2018

We'll consider regulatory options to speed up requiring companies to mitigate safety problems identified postmarket. Currently, mitigations such as new user training or new labeling can require rulemaking, which takes time and resources

We'll consider regulatory options to speed up requiring companies to mitigate safety problems identified postmarket. Currently, mitigations such as new user training or new labeling can require rulemaking, which takes time and resources

We'll consider regulatory options to speed up requiring companies to mitigate safety problems identified postmarket. Currently, mitigations such as new user training or new labeling can require rulemaking, which takes time and resources

FDA - U.S. Food and Drug Administration

5-6-2018

DuoTrav (Novartis Europharm Limited)

DuoTrav (Novartis Europharm Limited)

DuoTrav (Active substance: Travoprost / Timolol) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3622 of Tue, 05 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/665/T/53

Europe -DG Health and Food Safety